News + Filings Transactions
|
Tambi Brian
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/09/2019 | AKORN INC | AKRXQ | Grant | | 30.8k | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | AKORN INC | AKRXQ | Grant | Stock Options (Right to Buy) | 58.8k | $4.47 | $262.7k | | 05/09/2019 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 60k | $0.00 | $0 | | 02/21/2018 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 68.8k | $0.00 | $0 | | 02/21/2018 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 33.7k | $0.00 | $0 | | 02/21/2018 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Sale | Common Stock | 166.5k | $6.41 | $1.1M | | 02/21/2018 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Exercise | Common Stock | 60k | $3.63 | $217.8k | | 02/21/2018 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Exercise | Common Stock | 68.8k | $1.62 | $111.5k | | 02/21/2018 |
| 05/10/2018 | Insys Therapeutics, Inc. | INSY | Exercise | Common Stock | 33.7k | $0.61 | $20.5k | | 02/21/2018 |
| 04/19/2018 | AKORN INC | AKRXQ | Grant | Common Stock | 14.2k | $0.00 | $0 | | 04/19/2018 |
| 02/21/2018 | Insys Therapeutics, Inc. | INSY | Grant | Common Stock | 4k | $0.00 | $0 | | 02/21/2018 |
| 02/21/2018 | Insys Therapeutics, Inc. | INSY | Disposition | Restricted Stock Units | 4k | $0.00 | $0 | | 02/21/2018 |
| 11/21/2017 | AKORN INC | AKRXQ | Sale | Common Stock | 15.1k | $33.35 | $503.6k | | 11/21/2017 |
| 08/04/2017 | AKORN INC | AKRXQ | Sale | Common Stock | 5.2k | $33.37 | $172.4k | | 08/04/2017 |
| 02/21/2017 | Insys Therapeutics, Inc. | INSY | Grant | Restricted Stock Units | 4k | $0.00 | $0 | | 02/21/2017 |
| 02/21/2017 | Insys Therapeutics, Inc. | INSY | Grant | Employee Stock Option (right to buy) | 16k | $12.65 | $202.4k | | 02/21/2017 |
| 06/02/2016 | AKORN INC | AKRXQ | Sale | Common Stock | 25k | $30.73 | $768.2k | | 06/02/2016 |
| 06/02/2016 | AKORN INC | AKRXQ | Exercise | Stock Options (Right to Buy) | 25k | $2.61 | $65.2k | | 06/02/2016 |
| 06/02/2016 | AKORN INC | AKRXQ | Exercise | Stock Options (Right to Buy) | 25k | $6.62 | $165.5k | | 06/02/2016 |
| 05/02/2016 | Insys Therapeutics, Inc. | INSY | Grant | Stock Option (right to buy) | 25k | $14.44 | $361k | | 05/02/2016 |
| 05/27/2015 | Insys Therapeutics, Inc. | INSY | Sale | Common Stock | 3.1k | $60.09 | $186.3k | | 05/26/2015 |
| 05/27/2015 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 3.1k | $1.22 | $3.8k | | 05/26/2015 |
| 05/26/2015 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 1.8k | $1.22 | $2.2k | | 05/26/2015 |
| 05/26/2015 | Insys Therapeutics, Inc. | INSY | Sale | Common Stock | 1.8k | $60.00 | $108k | | 05/26/2015 |
| 05/20/2015 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 3.9k | $1.22 | $4.8k | | 05/19/2015 |
| 05/20/2015 | Insys Therapeutics, Inc. | INSY | Sale | Common Stock | 3.9k | $60.14 | $234.5k | | 05/19/2015 |
| 05/19/2015 | Insys Therapeutics, Inc. | INSY | Exercise | Stock Option (right to buy) | 1.2k | $0.00 | $0 | | 05/19/2015 |
| 05/19/2015 | Insys Therapeutics, Inc. | INSY | Exercise | Common Stock | 1.2k | $1.22 | $1.5k | | 05/19/2015 |
| 05/19/2015 | Insys Therapeutics, Inc. | INSY | Sale | Common Stock | 1.2k | $60.01 | $72k | | 05/19/2015 |
| 05/05/2015 | Insys Therapeutics, Inc. | INSY | Grant | Stock Option (right to buy) | 9k | $53.50 | $481.5k | | 05/05/2015 |
| 09/05/2014 | AKORN INC | AKRXQ | Grant | | 8k | $38.16 | $306.6k | | 09/05/2014 |
| 08/07/2014 | Insys Therapeutics, Inc. | INSY | Grant | Stock Option (right to buy) | 9k | $27.14 | $244.3k | | 08/07/2014 |
| 06/13/2014 | AKORN INC | AKRXQ | Purchase | Common Stock | 1000 | $27.62 | $27.6k | | 06/13/2014 |
| 05/02/2014 | AKORN INC | AKRXQ | Grant | Stock Options (Right to Buy) | 20k | $0.94 | $18.8k | | 05/02/2014 |
| 05/02/2014 | AKORN INC | AKRXQ | Grant | Stock Options (Right to Buy) | 10.8k | $24.74 | $266k | | 05/02/2014 |
|
|